GE HealthCare & Mayo Clinic Announce Theranostics Research Collaboration

GE HealthCare and Mayo Clinic have announced the MI-BET research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer.